… However, little is known about the pathogenesis and biomarkers of COVID-19. Here, we
profiled host responses to COVID-19 by performing plasma proteomics of a cohort of COVID-19 …

… The host response to COVID-19 pathophysiology over the first few days of infection remains
… proteomic analysis of acute-phase COVID-19 patients, for which we used blood plasma, …

… quantitative plasma proteomic analysis of COVID-19 patients and identified 1147 plasma …
prognosis and therapeutic monitoring [42] plasma proteomics is rather challenging due to its …

… In this study, we analyzed the changes in plasma proteomics and metabolomics of COVID-19
survivors 6 months after discharge from the hospital and found that COVID-19 survivors …

… plasma proteomics upon SARS-CoV-2 infection, we analyzed the protein profiles of plasma
samples from 10 COVID-19 … using the DIA quantitative proteomics technology. We compared …

… Here, we highlight the efficacy of combining moderate plasma … proteome coverage and
depth while remaining cost-efficient. Using human plasma collected from a 20-patient COVID-19 …

… soluble determinants of coronavirus disease 2019 (COVID-19) relative to aging by performing
mass cytometry in parallel with clinical blood testing and plasma proteomic profiling of ~…

… Here, we have used the PEA-NGS analysis to investigate the plasma proteome profile of
COVID-19 patients with mild to moderate symptoms to allow comprehensive comparisons of …

… -19 and present targets for candidate drugs to prevent or treat severe complications. Based
on the plasma proteomics and clinical lab tests, we also report a 12-plasma protein signature …

… We finish with a review of the timely progress in applications related to plasma proteomics,
including COVID-19 diagnostics, genetics, proteogenomics, hemostasis, aging research, and …